Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution
Arif Yurdagul, Na Kong, Brennan D. Gerlach, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 3
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 589
Inflammation Resolution: Implications for Atherosclerosis
Amanda C. Doran
Circulation Research (2022) Vol. 130, Iss. 1, pp. 130-148
Open Access | Times Cited: 103
Crosstalk Between Macrophages and Vascular Smooth Muscle Cells in Atherosclerotic Plaque Stability
Arif Yurdagul
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 4, pp. 372-380
Open Access | Times Cited: 74
Efferocytosis in atherosclerosis
Shaunak Adkar, Nicholas J. Leeper
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 762-779
Closed Access | Times Cited: 33
Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Chad Stroope, Felix Sebastian Nettersheim, Brian G. Coon, et al.
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 617-638
Open Access | Times Cited: 19
Through the layers: how macrophages drive atherosclerosis across the vessel wall
Leah I. Susser, Katey J. Rayner
Journal of Clinical Investigation (2022) Vol. 132, Iss. 9
Open Access | Times Cited: 55
Efferocytosis drives a tryptophan metabolism pathway in macrophages to promote tissue resolution
Santosh R. Sukka, Patrick B. Ampomah, Lancia Darville, et al.
Nature Metabolism (2024) Vol. 6, Iss. 9, pp. 1736-1755
Closed Access | Times Cited: 11
Directional Endothelial Communication by Polarized Extracellular Vesicle Release
Sneha Raju, Steven R. Botts, Mark C. Blaser, et al.
Circulation Research (2024) Vol. 134, Iss. 3, pp. 269-289
Open Access | Times Cited: 10
Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease
Sumit Kumar Anand, Theresea-Anne Governale, Xiangyu Zhang, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 4, pp. 510-524
Open Access | Times Cited: 9
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target
Rajan Pandit, Arif Yurdagul
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Ornithine decarboxylase supports ILC3 responses in infectious and autoimmune colitis through positive regulation of IL-22 transcription
Vincent Peng, Siyan Cao, Tihana Tršan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 45
Open Access | Times Cited: 31
Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis
Dhananjay Kumar, Rajan Pandit, Arif Yurdagul
Immunometabolism (2023) Vol. 5, Iss. 1, pp. e00017-e00017
Open Access | Times Cited: 20
Spatially Resolved Metabolites in Stable and Unstable Human Atherosclerotic Plaques Identified by Mass Spectrometry Imaging
Erin H. Seeley, Zhipeng Liu, Shuai Yuan, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 9, pp. 1626-1635
Open Access | Times Cited: 19
Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF)
Sungji Cho, Keith Dadson, Hye Kyoung Sung, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116119-116119
Open Access | Times Cited: 6
Efferocytosis: Current status and future prospects in the treatment of autoimmune diseases
Qianwei Li, Huan Liu, Geng Yin, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28399-e28399
Open Access | Times Cited: 6
Targeted Metabolomic Biomarkers for Stroke Subtyping
Eung‐Joon Lee, Da Jung Kim, Dong-Wan Kang, et al.
Translational Stroke Research (2023) Vol. 15, Iss. 2, pp. 422-432
Closed Access | Times Cited: 13
Mechanism of efferocytosis in atherosclerosis
Li-Xia Shu, Liu-li Cao, Xin Guo, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 7, pp. 831-840
Closed Access | Times Cited: 5
Metabolic Consequences of Efferocytosis and Its Impact on Atherosclerosis
Arif Yurdagul
Immunometabolism (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 27
Matrix‐Rigidity Cooperates With Biochemical Cues in M2 Macrophage Activation Through Increased Nuclear Deformation and Chromatin Accessibility
Seung Jae Shin, Buuvee Bayarkhangai, Khaliunsarnai Tsogtbaatar, et al.
Advanced Science (2025)
Open Access
Lipin-1 restrains macrophage lipid synthesis to promote inflammation resolution
Temitayo T. Bamgbose, Robert M. Schilke, Oluwakemi Osarumwense Igiehon, et al.
The Journal of Immunology (2025) Vol. 214, Iss. 1, pp. 85-103
Open Access
Structure simulation-based comparison of active site variations in fungal ornithine decarboxylases
Min Jeong Kim, Jeong Ho Chang
Communicative & Integrative Biology (2025) Vol. 18, Iss. 1
Open Access
Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution
Umesh Kumar Dhawan, Aarushi Singhal, Manikandan Subramanian
Pharmacological Research (2021) Vol. 170, pp. 105699-105699
Closed Access | Times Cited: 25
3, 3’-diindolylmethane enhances macrophage efferocytosis and subsequently relieves visceral pain via the AhR/Nrf2/Arg-1-mediated arginine metabolism pathway
Ling Yang, Chen Zheng, Yufeng Xia, et al.
Phytomedicine (2023) Vol. 116, pp. 154874-154874
Closed Access | Times Cited: 9
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease
Jishou Zhang, Wen Ding, Mengmeng Zhao, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 23, pp. 5151-5171
Closed Access | Times Cited: 15
2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis
Kai-Uwe Jarr, Yoko Kojima, Irving L. Weissman, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 6
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top